Form4insider filings, from the source

Company · CIK 0001649904 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

RHYTHM PHARMACEUTICALS, INC. · RYTM

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $32.5M · 7net −$32.5M
$10k$10k$1M$1M$100M$100MbuyssalesMar 28Apr 27May 28Jun 28Jul 29Aug 28Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 14, 2026 SForm 4 →Sep 14, 7:37 pm EDTDavid P MeekerPresident and CEO, Director50,000$102.67$5,133,442239,258−17.3%10b5-1
Sep 14, 2026 MForm 4 →Sep 14, 7:37 pm EDTDavid P MeekerPresident and CEO, Director50,000$6.05$302,500289,258—10b5-1
Aug 31, 2026 SForm 4 →Sep 1, 4:22 pm EDTHunter C SmithChief Financial Officer62,774$105.46$6,619,913114,024−35.5%10b5-1
Aug 31, 2026 MForm 4 →Sep 1, 4:22 pm EDTHunter C SmithChief Financial Officer57,187$25.79$1,474,853176,798—10b5-1
Aug 13, 2026 SForm 4 →Aug 17, 6:00 pm EDTJoseph ShulmanChief Technical Officer5,079$119.75$608,21015,915−24.2%10b5-1
Aug 13, 2026 MForm 4 →Aug 17, 6:00 pm EDTJoseph ShulmanChief Technical Officer2,024$6.80$13,76320,994—10b5-1
Aug 13, 2026 SForm 4 →Aug 17, 5:57 pm EDTAlastair GarfieldChief Scientific Officer7,763$117.57$912,7032,295−77.2%10b5-1
Aug 13, 2026 SForm 4 →Aug 14, 7:04 pm EDTJennifer Kayden LeeEVP, Head of North America75,834$117.38$8,901,5310−100%10b5-1
Aug 13, 2026 MForm 4 →Aug 14, 7:04 pm EDTJennifer Kayden LeeEVP, Head of North America56,601$17.62$997,03775,834—10b5-1
Aug 12, 2026 SForm 4 →Aug 14, 7:01 pm EDTYann MazabraudEVP, Head of International57,000$116.15$6,620,57555,655−50.6%10b5-1
Aug 12, 2026 MForm 4 →Aug 14, 7:01 pm EDTYann MazabraudEVP, Head of International46,625$6.80$317,050112,655—10b5-1
Jul 1, 2026 FMForm 4 →Jul 2, 4:52 pm EDTAlastair GarfieldChief Scientific Officer6,595$110.41$237,38210,058—
Jun 23, 2026 MForm 4 →Jun 25, 6:09 pm EDTChristophe JeanDirector4,712——11,712—
Jun 23, 2026 MForm 4 →Jun 25, 6:08 pm EDTDavid W J McGirrDirector4,712——11,712—
Jun 23, 2026 MForm 4 →Jun 25, 6:06 pm EDTLynn A. TetraultDirector4,712——11,712—
Jun 23, 2026 MForm 4 →Jun 25, 6:03 pm EDTStuart A ArbuckleDirector4,712——11,712—
Jun 23, 2026 MForm 4 →Jun 25, 6:01 pm EDTJennifer L GoodDirector4,712——11,712—
Jun 22, 2026 SForm 4 →Jun 24, 4:15 pm EDTLynn A. TetraultDirector37,000$100.32$3,711,8967,000−84.1%10b5-1
Jun 22, 2026 MForm 4 →Jun 24, 4:15 pm EDTLynn A. TetraultDirector37,000$28.27$1,045,99044,000—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 14, 2026 MForm 4 →Sep 14, 7:37 pm EDTDavid P MeekerPresident and CEO, Director50,000——15,431—10b5-1
Aug 31, 2026 MForm 4 →Sep 1, 4:22 pm EDTHunter C SmithChief Financial Officer57,187——3,813—10b5-1
Aug 17, 2026 AForm 4 →Aug 18, 5:35 pm EDTManher JoshiChief Medical Officer75,000——25,000—
Aug 13, 2026 MForm 4 →Aug 17, 6:00 pm EDTJoseph ShulmanChief Technical Officer2,024——5,945—10b5-1
Aug 13, 2026 MForm 4 →Aug 14, 7:04 pm EDTJennifer Kayden LeeEVP, Head of North America56,601——0—10b5-1
Aug 12, 2026 MForm 4 →Aug 14, 7:01 pm EDTYann MazabraudEVP, Head of International46,625——35,875—10b5-1
Jul 1, 2026 MForm 4 →Jul 2, 4:52 pm EDTAlastair GarfieldChief Scientific Officer4,445——8,888—
Jun 23, 2026 AMForm 4 →Jun 25, 6:09 pm EDTChristophe JeanDirector10,727——2,324—
Jun 23, 2026 AMForm 4 →Jun 25, 6:08 pm EDTDavid W J McGirrDirector10,727——2,324—
Jun 23, 2026 AMForm 4 →Jun 25, 6:06 pm EDTLynn A. TetraultDirector10,727——2,324—
Jun 23, 2026 AMForm 4 →Jun 25, 6:03 pm EDTStuart A ArbuckleDirector10,727——2,324—
Jun 23, 2026 AMForm 4 →Jun 25, 6:01 pm EDTJennifer L GoodDirector10,727——2,324—
Jun 22, 2026 MForm 4 →Jun 24, 4:15 pm EDTLynn A. TetraultDirector37,000——0—10b5-1